Cy5.5 NHS Ester: Advanced Near-Infrared Dye for Biomolecule Labeling

Principle and Setup: The Power of Near-Infrared Fluorescent Labeling

Cy5.5 NHS ester (non-sulfonated) has emerged as a transformative near-infrared fluorescent dye for biomolecule labeling. Its NHS (N-hydroxysuccinimide) ester group reacts efficiently and selectively with primary amines, typically found in lysine residues of proteins and the 5' ends of oligonucleotides. This chemistry forms a stable amide bond, locking the dye into the target biomolecule and ensuring durability during downstream applications.

What sets Cy5.5 NHS ester apart is its excitation maximum at 684 nm and emission at 710 nm (often referred to as Cy5.5 excitation emission or cy5 5 excitation emission). This near-infrared window allows for deep tissue penetration and reduced background autofluorescence, making it exceptionally valuable for in vivo fluorescence imaging and tumor imaging agent applications. Its high solubility in organic solvents like DMSO (≥35.82 mg/mL) further supports efficient labeling reactions, although its low aqueous solubility necessitates careful protocol design.

Supplied as a solid and stable for 24 months at -20°C (protected from light), Cy5.5 NHS ester (non-sulfonated) from APExBIO is trusted by molecular imaging specialists for robust, reproducible results. For further technical details and purchasing information, visit the Cy5.5 NHS ester (non-sulfonated) product page.

Step-by-Step Workflow: Protocol Enhancements for High-Efficiency Labeling

1. Preparation and Dissolution

• Equilibrate reagents: Allow Cy5.5 NHS ester (non-sulfonated) to warm to room temperature in the dark before opening the vial.
• Dissolve immediately before use: Prepare a fresh stock solution in anhydrous DMSO or DMF at 10–20 mM. The dye is not stable in solution; minimize freeze-thaw cycles and exposure to light.
• Avoid water contact: Due to poor aqueous solubility, ensure organic co-solvent is thoroughly mixed before introducing to aqueous buffer.

2. Buffer Selection and Biomolecule Preparation

• Use amine-free buffers: Opt for phosphate buffer (pH 7.4–8.5). Avoid Tris, glycine, or other primary amine-containing buffers that will compete for labeling.
• Desalt or buffer-exchange biomolecules: Remove any small molecule amines or other contaminants using desalting columns or dialysis.

3. Conjugation Reaction

• Add Cy5.5 NHS ester stock dropwise to the biomolecule solution while gently mixing. Maintain a typical dye:biomolecule molar ratio between 3:1 and 10:1, depending on the desired degree of labeling (DOL).
• Incubate at room temperature (20–25°C) for 30–120 minutes, protected from light. For proteins, a DOL of 2–5 is often optimal for imaging without impacting function.

4. Purification

• Remove excess dye: Employ size-exclusion chromatography or ultrafiltration. Thorough purification is essential for minimizing background and ensuring probe specificity in imaging.

5. Characterization and Storage

• Quantify DOL: Use UV-Vis spectroscopy to measure absorbance at 280 nm (protein) and 684 nm (Cy5.5). Calculate DOL using published extinction coefficients.
• Store conjugates at 4°C (short term) or -20°C (long term), protected from light. Avoid repeated freeze-thaw cycles.

For detailed protocol comparisons and stepwise troubleshooting, the article "Cy5.5 NHS Ester (Non-Sulfonated): Reliable Labeling for High-Sensitivity Imaging Workflows" offers practical Q&A blocks and optimization strategies.

Advanced Applications: Deep-Tissue Imaging, Tumor Microbiome, and Beyond

Cy5.5 NHS ester (non-sulfonated) is at the forefront of fluorescent labeling in molecular biology, particularly for optical imaging of tumors and dissecting the complex tumor microenvironment. Its spectral characteristics—far-red excitation and emission—enable:

• In vivo fluorescence imaging of tumors in live animal models, with clear delineation and minimal autofluorescence.
• Tracking antibody, peptide, or nanoparticle biodistribution in preclinical pharmacokinetic studies.
• Labeling and imaging of tumor-associated microbiota to investigate the link between intratumoral bacteria and cancer metastasis.

Notably, a recent Science Advances study (Kang et al., 2025) deployed near-infrared dyes like Cy5.5 NHS ester to visualize and quantify vaccine-induced clearance of tumor-associated bacteria, providing actionable insights into microbiome modulation for cancer therapy. The study demonstrated that selective targeting of bacteria such as Fusobacterium nucleatum within the tumor microenvironment led to reduced metastasis and improved therapeutic outcomes—showcasing the critical role of advanced fluorescent labels in translational oncology.

For a mechanistic deep dive into the translational impact of Cy5.5 NHS ester (non-sulfonated), see "Illuminating Translational Breakthroughs"—this article complements the current workflow by offering context on neuromodulation and biomimetic nanoplatforms.

Comparative evaluations, as highlighted in "Illuminating New Pathways in Tumor Imaging and Microbiome", extend these findings by integrating evidence linking intratumoral microbiomes to metastasis and suggesting how precision labeling can drive innovative diagnostics and therapeutics.

Troubleshooting & Optimization: Overcoming Common Pitfalls

1. Poor Labeling Efficiency

• Check solvent freshness: Use freshly opened, anhydrous DMSO or DMF.
• pH matters: Ensure buffer pH is 7.4–8.5; lower pH reduces NHS ester reactivity.
• Remove amine contaminants: Even trace amines from buffers or stabilizers can compete for labeling sites.

2. High Background or Free Dye Signal

• Optimize purification: Incomplete removal of free dye is the most common issue. Employ multiple rounds of desalting or size-exclusion chromatography if needed.
• Validate with controls: Include unmodified biomolecule and dye-only controls to assess background.

3. Protein Aggregation or Loss of Activity

• Avoid over-labeling: Excessive DOL can disrupt protein structure and function. Start with a lower dye:protein ratio and titrate upward as needed.
• Gentle mixing: Prevent aggregation by avoiding vigorous shaking during conjugation.

4. Photobleaching or Signal Loss

• Light protection: Always perform reactions and store conjugates in the dark.
• Aliquot and freeze: Minimize freeze-thaw cycles and aliquot labeled biomolecules for single-use applications.

For advanced troubleshooting, the article "Cy5.5 NHS Ester (Non-Sulfonated): Enabling Next-Gen In Vivo Imaging" extends the discussion to neuromodulation and complex in vivo setups, offering solutions for challenging scenarios.

Future Outlook: Next-Generation Tumor Imaging and Microbiome Modulation

The future of near-infrared fluorescence imaging is being shaped by reagents like Cy5.5 NHS ester (non-sulfonated), which deliver the sensitivity and specificity needed for precision oncology, immunotherapy, and tumor imaging agent development. As shown in the reference study (Kang et al., 2025), advanced fluorescent dyes are central to unraveling the interplay between cancer, the microbiome, and therapeutic response.

Emerging applications include:

• Multiplexed imaging: Simultaneous tracking of multiple biomolecules or cell types using distinct NIR dyes.
• Real-time intraoperative guidance: Utilizing Cy5.5 NHS ester-labeled probes for fluorescence-guided surgery and margin assessment.
• Functional microbiome imaging: Mapping bacterial dynamics in vivo to guide microbiome-targeted therapies.

In summary, Cy5.5 NHS ester (non-sulfonated) stands as a cornerstone reagent for advanced amino group labeling, fluorescent dye for protein conjugation, and innovative imaging workflows. Its unparalleled spectral properties, robust chemistry, and proven translational impact make it indispensable for life sciences research at the intersection of molecular imaging, microbiology, and cancer biology. For researchers demanding reliable performance and expert support, APExBIO remains the preferred source for high-purity Cy5.5 NHS ester and related labeling reagents.